Macrophages at the fork in the road to health or disease

Frontiers in Immunology

Volumn 6, Issue FEB, 2015, Pages

  Mills, Charles D ^a   Lenz, Laurel L ^b   Ley, Klaus ^c  

^a BioMedical Consultants   (United States)

^b UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^c LA JOLLA INSTITUTE FOR ALLERGY AND IMMUNOLOGY   (United States)

Author keywords

Atherosclerosis; Cancer; Infection; Innate immunity; M1; M2; Macrophage; Wound

Indexed keywords

ARGININE; COLONY STIMULATING FACTOR; GAMMA INTERFERON; MACROPHAGE ACTIVATING FACTOR; NITRIC OXIDE; SUPPRESSOR OF CYTOKINE SIGNALING;

ADAPTIVE IMMUNITY; ATHEROSCLEROSIS; CELL DIFFERENTIATION; EDITORIAL; HUMAN; IMMUNE RESPONSE; INFECTION; INNATE IMMUNITY; MACROPHAGE; MACROPHAGE FUNCTION; NEOPLASM; NONHUMAN; WOUND; WOUND HEALING;

EID: 84926629267     PISSN: None     EISSN: 16643224     Source Type: Journal    
DOI: 10.3389/fimmu.2015.00059     Document Type: Editorial

References (56)

1. Mills CD, Ley K. M1 and M2 macrophages: the chicken and the egg of immunity. J Innate Immun (2014) 6:716-26. doi: 10.1159/000364945
2. Metchnikoff E. Untersuchungen uber die intracellulare Verdauung bei Wirbellosen Thieren. Arbeit Zoologischen Instituten, Universitat Wien (1883) 5:141-68.
3. Mills CD. M1 and M2 macrophages: oracles of health and disease. Crit Rev Immunol (2012) 32:463-88. doi:10.1615/CritRevImmunol.v32.i6.10
4. Mills CD, Kincaid K, Alt JM, Heilman MJ, Hill AM. M-1/M-2 macrophages and the Th1/Th2 paradigm. J Immunol (2000) 164:6166-73. doi:10.4049/jimmunol.164.12.6166
5. Mills CD. Macrophage arginine metabolism to ornithine/urea or nitric oxide/citrulline: a life or death issue. Crit Rev Immunol (2001) 21:399-425. doi:10.1615/CritRevImmunol.v21.i5.10
6. Currie GA, Gyure L, Cifuentes L. Microenvironmental arginine depletion by macrophages in vivo. Br J Cancer (1979) 39:613-20. doi:10.1038/bjc.1979.112
7. Hibbs JB, Vavrin Z, Taintor RR. L-arginine is required for expression of the activated macrophage effector mechanism causing selective metabolic inhibition in target cells. J Immunol (1987) 138:550-65.
8. Albina JE, Caldwell MD, Henry WL, Mills CD. Regulation of macrophage functions by L-arginine. J Exp Med (1989) 169:1021-9. doi:10.1084/jem.169.3.1021
9. Albina JE, Mills CD, Henry WL, Caldwell MD. Temporal expression of different pathways of 1-arginine metabolism in healing wounds. J Immunol (1990) 144:3877-80.
10. Nathan CF, Hibbs JB. Role of nitric oxide synthesis in macrophage antimicrobial activity. Curr Opin Immunol (1991) 3:65-70. doi:10.1016/0952-7915(91)90079-G
11. Mills CD, Shearer J, Evans R, Caldwell MD. Macrophage arginine metabolism and the inhibition or stimulation of cancer. J Immunol (1992) 149:2709-14.
12. Wu G, Morris SM. Arginine metabolism: nitric oxide and beyond. Biochem J (1998) 336(Pt 1):1-17.
13. Dzik JM. The ancestry and cumulative evolution of immune reactions. Acta Biochim Pol (2010) 57:443-66.
14. Rath M, Müller I, Kropf P, Closs EI, Munder M. Metabolism via arginase or nitric oxide synthase: two competing arginine pathways in macrophages. Front Immunol (2014) 5:532. doi:10.3389/fimmu.2014.00532
15. Buchmann K. Evolution of innate immunity: clues from invertebrates via fish to mammals. Front Immunol (2014) 5:459. doi:10.3389/fimmu.2014.00459
16. Dzik JM. Evolutionary roots of arginase expression and regulation. Front Immunol (2014) 5:544. doi:10.3389/fimmu.2014.00544
17. Mills CD, Thomas AC, Lenz LL, Munder M. Macrophage: SHIP of Immunity. Front Immunol (2014) 5:620. doi:10.3389/fimmu.2014.00620
18. Italiani P, Boraschi D. From monocytes to M1/M2 macrophages: phenotypical vs. functional differentiation. Front Immunol (2014) 5:514. doi:10.3389/fimmu.2014.00514
19. Harris RA. Spatial, temporal, and functional aspects of macrophages during "the good, the bad, and the ugly" phases of inflammation. Front Immunol (2014) 5:612. doi:10.3389/fimmu.2014.00612
20. Thomas AC, Mattila JT. "Of mice and men": arginine metabolism in macrophages. Front Immunol (2014) 5:479. doi:10.3389/fimmu.2014.00479
21. Schneemann M, Schoedon G. Species differences in macrophage NO production are important. Nat Immunol (2002) 3:102-102. doi:10.1038/ni0202-102a
22. Martinez FO, Gordon S, Locati M, Mantovani A. Transcriptional profiling of the human monocyte-to-macrophage differentiation and polarization: new molecules and patterns of gene expression. J Immunol (2006) 177:7303-11. doi:10.4049/jimmunol.177.10.7303
23. Sica A, Schioppa T, Mantovani A, Allavena P. Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur J Cancer (2006) 42:717-27. doi:10.1016/j.ejca.2006.01.003
24. Baay M, Brouwer A, Pauwels P, Peeters M, Lardon F. Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. Clin Dev Immunol (2011) 2011:565187. doi:10.1155/2011/565187
25. Noy R, Pollard JW. Tumor-associated macrophages: from mechanisms to therapy. Immunity (2014) 41:49-61. doi:10.1016/j.immuni.2014.06.010
26. Brown BN, Sicari BM, Badylak SF. Rethinking regenerative medicine: a macrophage-centered approach. Front Immunol (2014) 5:510. doi:10.3389/fimmu.2014.00510
27. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol (2011) 11:723-37. doi:10.1038/nri3073
28. Beljaars L, Schippers M, Reker-Smit C, Martinez FO, Helming L, Poelstra K, et al. Hepatic localization of macrophage phenotypes during fibrogenesis and resolution of fibrosis in mice and humans. Front Immunol (2014) 5:430. doi:10.3389/fimmu.2014.00430
29. Chazaud B. Macrophages: supportive cells for tissue repair and regeneration. Immunobiology (2014) 219:172-8. doi:10.1016/j.imbio.2013.09.001
30. Mosser DM, Edwards JP. Exploring the full spectrum of macrophage activation. Nat Rev Immunol (2008) 8:958-69. doi:10.1038/nri2448
31. Dvorak HF. Tumors: wounds that do not heal. Similarities between tumor stroma generation and wound healing. N Engl J Med (1986) 315:1650-9. doi:10.1056/NEJM198612253152606
32. Beatty GL, Chiorean EG, Fishman MP, Saboury B, Teitelbaum UR, Sun W, et al. CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans. Science (2011) 331:1612-6. doi:10.1126/science.1198443
33. Swanson MS, Sinha UK. Rationale for combined blockade of PD-1 and CTLA-4 in advanced head and neck squamous cell cancer-review of current data. Oral Oncol (2015) 51:12-5. doi:10.1016/j.oraloncology.2014.10.010
34. Laoui D, Van Overmeire E, De Baetselier P, Van Ginderachter JA, Raes G. Functional relationship between tumor-associated macrophages and macrophage colony-stimulating factor as contributors to cancer progression. Front Immunol (2014) 5:489. doi:10.3389/fimmu.2014.00489
35. Fritz JM, Tennis MA, Orlicky DJ, Lin H, Ju C, Redente EF, et al. Depletion of tumor-associated macrophages slows the growth of chemically induced mouse lung adenocarcinomas. Front Immunol (2014) 5:587. doi:10.3389/fimmu.2014.00587
36. Cole C, Thomas S, Filak H, Henson PM, Lenz LL. Nitric oxide increases susceptibility of toll-like receptor-activated macrophages to spreading Listeria monocytogenes. Immunity (2012) 36:807-20. doi:10.1016/j.immuni.2012.03.011
37. Ka MB, Daumas A, Textoris J, Mege J-L. Phenotypic diversity and emerging new tools to study macrophage activation in bacterial infectious diseases. Front Immunol (2014) 5:500. doi:10.3389/fimmu.2014.00500
38. Burrack KS, Morrison TE. The role of myeloid cell activation and arginine metabolism in the pathogenesis of virus-induced diseases. Front Immunol (2014) 5:428. doi:10.3389/fimmu.2014.00428
39. Hayes EM, Tsaousi A, Gregoli KD, Jenkinson SR, Bond AR, Johnson JL, et al. Classical and alternative activation and metalloproteinase expression occurs in foam cell macrophages in male and female ApoE null mice in the absence of T and B lymphocytes. Front Immunol (2014) 5:537. doi:10.3389/fimmu.2014.00537
40. Murphy AJ, Dragoljevic D, Tall AR. Cholesterol efflux pathways regulate myelopoiesis: a potential link to altered macrophage function in atherosclerosis. Front Immunol (2014) 5:490. doi:10.3389/fimmu.2014.00490
41. Peled M, Fisher EA. Dynamic aspects of macrophage polarization during atherosclerosis progression and regression. Front Immunol (2014) 5:579. doi:10.3389/fimmu.2014.00579
42. Yang Z, Ming XF. Functions of arginase isoforms in macrophage inflammatory responses: impact on cardiovascular diseases and metabolic disorders. Front Immunol (2014) 5:533. doi:10.3389/fimmu.2014.00533
43. Vlahos R, Bozinovski S. Role of alveolar macrophages in chronic obstructive pulmonary disease. Front Immunol (2014) 5:435. doi:10.3389/fimmu.2014.00435
44. Kraakman MJ, Murphy AJ, Jandeleit-Dahm K, Kammoun HL. Macrophage polarization in obesity and type 2 diabetes: weighing down our understanding of macrophage function? Front Immunol (2014) 5:470. doi:10.3389/fimmu.2014.00470
45. Cherry JD, Olschowka JA, O'Banion MK. Are "resting" microglia more "M2"? Front Immunol (2014) 5:594. doi:10.3389/fimmu.2014.00594
46. Okabe Y, Medzhitov R. Tissue-specific signals control reversible program of localization and functional polarization of macrophages. Cell (2014) 157:832-44. doi:10.1016/j.cell.2014.04.016
47. Brown MB, von Chamier M, Allam AB, Reyes L. M1/M2 macrophage polarity in normal and complicated pregnancy. Front Immunol (2014) 5:606. doi:10.3389/fimmu.2014.00606
48. Dey A, Allen J, Hankey-Giblin PA. Ontogeny and polarization of macrophages in inflammation: blood monocytes versus tissue macrophages. Front Immunol (2014) 5:683. doi:10.3389/fimmu.2014.00683
49. Wang N, Liang H, Zen K. Molecular mechanisms that influence the macrophage M1-M2 polarization balance. Front Immunol (2014) 5:614. doi:10.3389/fimmu.2014.00614
50. Wilson HM. SOCS proteins in macrophage polarization and function. Front Immunol (2014) 5:357. doi:10.3389/fimmu.2014.00357
51. Hamilton TA, Zhao C, Pavicic PG, Datta S. Myeloid colony-stimulating factors as regulators of macrophage polarization. Front Immunol (2014) 5:554. doi:10.3389/fimmu.2014.00554
52. Chaudhuri A. Regulation of macrophage polarization by RON receptor tyrosine kinase signaling. Front Immunol (2014) 5:546. doi:10.3389/fimmu.2014.00546
53. Bohlson SS, O'Conner SD, Hulsebus HJ, Ho M-M, Fraser DA. Complement, C1q, and C1q-related molecules regulate macrophage polarization. Front Immunol (2014) 5:402. doi:10.3389/fimmu.2014.00402
54. Desai BN, Leitinger N. Purinergic and calcium signaling in macrophage function and plasticity. Front Immunol (2014) 5:580. doi:10.3389/fimmu.2014.00580
55. Mattila JT, Thomas AC. Nitric oxide synthase: non-canonical expression patterns. Front Immunol (2014) 5:478. doi:10.3389/fimmu.2014.00478
56. Galván-Peña S, O'Neill LAJ. Metabolic reprograming in macrophage polarization. Front Immunol (2014) 5:420. doi:10.3389/fimmu.2014.00420